Search Results
Apr 28, 2025, 14:02 ET CS Genetics Appoints Paul McEwan as Independent Board Director
a radically new, instrument-free platform for single-cell genomics with disruptive simplicity, speed, and scalability that will launch a new era of NGS-based cellular analysis. The company's technology leverages a molecular process known as Kinetic Confinement that is categorically different to other
More news about: CS Genetics
Apr 25, 2025, 14:45 ET BillionToOne to Present New Data at AACR Annual Meeting 2025
precision diagnostics company on a mission to make molecular diagnostics more accurate, efficient, and accessible for all. The company's single-molecule NGS (smNGS) platform, which includes the patented Quantitative Counting Template (QCT) technology, is the only multiplex methodology that can accurately
More news about: BillionToOne
Apr 24, 2025, 06:30 ET Caris Life Sciences Collaborates with Meaningful Insights Biotech Analytics (MiBA) to Advance Oncology Education and Quality of Care
partnership aims to help improve patient care and advance precision medicine by supporting oncologists' experience with Next Generation Sequencing (NGS) testing and supporting clinical research through operational optimization, BioPharma clinical trials and real-world data project identification.
More news about: Caris Life Sciences
Apr 23, 2025, 10:00 ET Meridian Bioscience Introduces New Enzyme Stabilization Services for Molecular Diagnostics
announced the expansion of its contract services, enabling assay developers working with qPCR, isothermal amplification, or next-generation sequencing (NGS) technologies to achieve enhanced assay stability, lower limits of detection (LOD), and improved cost efficiencies through Meridian's advanced enzyme
More news about: Meridian Bioscience, Inc.
Apr 23, 2025, 08:00 ET Dovetail Genomics Unveils Ultra-Sensitive Somatic Variant Detection and AI-Driven Analysis Ahead of AACR 2025
variants (SVs) using NGS platforms. The solution offers ultra-sensitive discovery of SVs at base-pair resolution down to 1% variant allele frequency (VAF), and biologically meaningful interpretation of SVs through AI-driven tools in a powerful, cloud-based informatics platform. The NGS-based solution is
More news about: Dovetail Genomics
Apr 23, 2025, 05:42 ET Tsingke Gene Leads a Delivery Revolution with "Calendar Day Delivery"
Assembly Efficiency: Increased capability for multi-fragment synthesis. 4. Upgraded Detection Technology: Dual assurance with Sanger sequencing and NGS. 5. Smart Production System: MES system management with meticulous control at every step. According to Tsingke Gene Synthesis Director,
More news about: Tsingke Biotech
Apr 23, 2025, 05:18 ET Tsingke Gene Leads a Delivery Revolution with "Calendar Day Delivery"
Assembly Efficiency: Increased capability for multi-fragment synthesis. 4. Upgraded Detection Technology: Dual assurance with Sanger sequencing and NGS. 5. Smart Production System: MES system management with meticulous control at every step. According to Tsingke Gene Synthesis Director,
More news about: Tsingke Biotech
Apr 22, 2025, 09:00 ET 1Cell.Ai, Formerly OneCell Diagnostics, Launches OncoIncytes Integrating Multi-Modal Data for Precision Oncology
Foster City has recently been CLIA-certified. The 1080 gene panel was validated against an orthogonal NGS panel, Illumina's TSO 500 and the FDA cleared PGDx panel at Dr. Ravindra Kohle's laboratory at Augusta
More news about: 1Cell.Ai
Apr 22, 2025, 06:49 ET GENE SOLUTIONS AND ELEMENT BIOSCIENCES ENTER STRATEGIC COLLABORATION TO ADVANCE NEXT-GENERATION SEQUENCING (NGS) TECHNOLOGY GLOBALLY
a leading innovator in the next generation sequencing (NGS) field, delivering novel solutions that provide exceptional performance and flexibility for researchers. Gene Solutions, with its comprehensive portfolio of genetic tests, leveraging NGS and artificial intelligence, has reached over 4,500 hospitals
More news about: Gene Solutions Genomics Pte Ltd
Apr 21, 2025, 07:31 ET 亞洲首個ctDNA-MRD真實世界研究成果發布，為高性價比癌症監測提供有力證據
多家醫院和診所合作，擁有一支由約 250 名生物學專家和技術人員組成的專業團隊，員工總數達 700 人。 Gene Solutions 已在東南亞地區發表了 50 多篇同行評審的論文，並開展了 50 多項多中心研究，其自主研發成果以及位於新加坡和越南的 CAP 認證的新一代測序 (NGS) 實驗室備受認可。通過將多維基因組學與人工智能驅動的方法相結合，公司致力於變革癌症治療，令更多癌症患者受益。 Hoang, V.-A.N. et al. (2025) 'Real-World utilization
More news about: Gene Solutions Genomics Pte Ltd
Apr 17, 2025, 10:30 ET Immune Repertoire Sequencing Market worth US$560.5 million by 2030 with 9.6% CAGR | MarketsandMarkets™
pressure from Illumina in TCR/BCR profiling. The July 2024 acquisition of Olink Holding AB strengthens its proteomics and NGS integration, enhancing immune monitoring capabilities. Strategic expansion and diagnostics-focused development remain key elements of its market presence.
More news about: MarketsandMarkets
Apr 16, 2025, 09:00 ET BillionToOne Announces Medicare Coverage for Northstar Select®
Northstar Select® is an ultra-sensitive, 84-gene next-generation sequencing (NGS)-based ctDNA panel that helps oncologists identify genomic alterations in patients with advanced solid tumors to guide therapy selection. This non-invasive,
More news about: BillionToOne
Apr 11, 2025, 10:15 ET Africa IVD Market to Reach $1.7 Billion by 2032, Growing at a CAGR of 3.1% from 2025--Exclusive Report by Meticulous Research®
Furthermore, the rising focus on personalized medicine and growing investment in advanced testing platforms like PCR and next-generation sequencing (NGS) are accelerating the adoption of molecular techniques. As infrastructure improves and costs decline, molecular diagnostics is becoming more accessible
More news about: Meticulous Market Research Pvt. Ltd.
Apr 10, 2025, 08:30 ET ePlus Earns NVIDIA DGX SuperPOD Specialization Partner Status
HERNDON, Va., April 10, 2025 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS –
More news about: EPLUS INC.